The authors briefly summarize the history of the research on the cervical cancer (CC) which has resulted in the
recognition of human papillomaviruses (HPV) as the key etiological factors in CC. They describe the HPV properties
and the process leading to the development of prophylactic vaccines directed against HPV genotypes most frequently
responsible for the development of CC. They summarize the results of the recent studies with these vaccines and
strongly recommend their introduction. At the same time they stress that the vaccination programs must not disturb
the present system of preventive gynecological check–ups. These will remain the most efficient weapon in the war
against CC for at least two decades.
cervical cancer uteri, prophylactic vaccine.